Patents by Inventor Karin G. Steppuhn

Karin G. Steppuhn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5614509
    Abstract: The use of NMDA receptor antagonists or their physiologically compatible salts for preventing the development of tolerance during the long-term treatment with benzodiazepine-receptor-binding active ingredients as well as the combination of new pharmaceutical agents with benzodiazepine-receptor-binding active ingredients is described.
    Type: Grant
    Filed: March 2, 1995
    Date of Patent: March 25, 1997
    Assignee: Schering Aktiengesellschaft
    Inventors: Lechoslaw Turski, Karin G. Steppuhn, Herbert Schneider, David N. Stephens
  • Patent number: 5385903
    Abstract: The use of the non-NMDA receptor antagonists quisqualate or kainate antagonists or their physiologically compatible salts for treatment of withdrawal symptoms after drug abuse as well as the combination of the new pharmaceutical agents with NMDA antagonists are described.
    Type: Grant
    Filed: July 9, 1992
    Date of Patent: January 31, 1995
    Assignee: Schering Aktiengesellschaft
    Inventors: Karin G. Steppuhn, Karin Bressler, Martin Gieseler, David N. Stephens, Lechoslaw Turski